[go: up one dir, main page]

AU2003297739A1 - Prodrugs for use a ophthalmic agents - Google Patents

Prodrugs for use a ophthalmic agents

Info

Publication number
AU2003297739A1
AU2003297739A1 AU2003297739A AU2003297739A AU2003297739A1 AU 2003297739 A1 AU2003297739 A1 AU 2003297739A1 AU 2003297739 A AU2003297739 A AU 2003297739A AU 2003297739 A AU2003297739 A AU 2003297739A AU 2003297739 A1 AU2003297739 A1 AU 2003297739A1
Authority
AU
Australia
Prior art keywords
prodrugs
ophthalmic agents
ophthalmic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003297739A
Other versions
AU2003297739A8 (en
Inventor
Neeraj Agarwal
Katalin Prokai
Laszlo Prokai
James Simpkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of North Texas Health Science Center
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/405,413 external-priority patent/US7026306B2/en
Application filed by University of Florida filed Critical University of Florida
Publication of AU2003297739A1 publication Critical patent/AU2003297739A1/en
Publication of AU2003297739A8 publication Critical patent/AU2003297739A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU2003297739A 2002-12-09 2003-12-09 Prodrugs for use a ophthalmic agents Abandoned AU2003297739A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43235402P 2002-12-09 2002-12-09
US60/432,354 2002-12-09
US10/405,413 US7026306B2 (en) 2002-04-01 2003-04-01 Steroidal quinols and their use for antioxidant therapy
US10/405,413 2003-04-01
PCT/US2003/038987 WO2004069248A1 (en) 2002-12-09 2003-12-09 Prodrugs for use a ophthalmic agents

Publications (2)

Publication Number Publication Date
AU2003297739A1 true AU2003297739A1 (en) 2004-08-30
AU2003297739A8 AU2003297739A8 (en) 2004-08-30

Family

ID=32853159

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003297739A Abandoned AU2003297739A1 (en) 2002-12-09 2003-12-09 Prodrugs for use a ophthalmic agents

Country Status (3)

Country Link
EP (1) EP1569648A4 (en)
AU (1) AU2003297739A1 (en)
WO (1) WO2004069248A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2910486A (en) * 1957-12-20 1959-10-27 Searle & Co 10-hydroxyestra-1, 4-diene-3, 17-dione and acetate
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
PT841929E (en) * 1995-08-02 2003-09-30 Darwin Discovery Ltd QUINOLONES AND THEIR THERAPEUTIC UTILIZATION
DE19654750A1 (en) * 1996-12-30 1998-07-02 Helmut Dr Med Zander Use of active ingredients with an estrogenic effect for the prevention and treatment of macular degeneration
EP1330467B1 (en) * 2000-11-03 2007-05-02 Washington University Modified, hydroxy-substituted aromatic structures having cytoprotective activity
WO2003084978A1 (en) * 2002-04-01 2003-10-16 University Of Florida Steroidal quinols as prodrugs of antioxidants

Also Published As

Publication number Publication date
EP1569648A4 (en) 2006-10-04
AU2003297739A8 (en) 2004-08-30
EP1569648A1 (en) 2005-09-07
WO2004069248A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
AU2003281987A1 (en) A dressing
AUPS130302A0 (en) A wheeled arrangement
AU2002952684A0 (en) A device
AU2003255813A1 (en) A dispenser
AU2003208404A1 (en) A couplig
AU2002952772A0 (en) A corneal topographer
AU2003215884A1 (en) A bioadhesive agent
AU2003902474A0 (en) A bioelastomer i
AU2003255730A1 (en) Dressing for a four legged animal
AU2003235562A1 (en) A spraying device
AU2003283555A1 (en) A blast-absorbing device
AU2003301286A1 (en) A spray device
AU2003254149A1 (en) Hydrophilic components for a spin-rinse-dryer
AU2003297739A1 (en) Prodrugs for use a ophthalmic agents
AU2003235216A1 (en) Bag for a pupil
AUPS027802A0 (en) A dispenser
AU2003255072A1 (en) A hand muff
AU2003299937A1 (en) Attachment for a tool
AU2003242505A1 (en) Extinguisher designed for use on a candle
AU2003205530A1 (en) Sleeve for a score-card
AU2003219026A1 (en) A bird-frightening device
AU2002308929A1 (en) A detachably accessory eyeglasses
AU2003205643A1 (en) A holder
AU2003901074A0 (en) A holster
AU2003303113A1 (en) Device for mending a netpen

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 38, PAGE(S) 9323 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME UNIVERSITY OF FLORIDA, APPLICATION NO. 2003297739, UNDER INID (71) CORRECT THE NAME TO READ UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER; UNIVERSITY OF FLORIDA